Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where …

Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where …

[7,12] Based on these data, THP is considered the current standard of care for first-line treatment of HER2-positive metastatic breast cancer (Figure 2), as per the National Comprehensive Cancer Network (NCCN) guidelines.[13] As outlined in the

(Visited 2 times, 1 visits today)
1
Like
Save

Comments

Comments are disabled for this post.